April 6, 2022
Early risk – Early intervention: Overdose among Youth
Changing drug markets and the COVID-19 pandemic have created an increasingly serious need to develop specific solutions for young people at risk of overdose. Everyone is welcome to join the conversations about early intervention, prevention and youth-focused treatments for high-risk substance use.
In the midst of a pandemic, a polluted planet, increasing diseases like cancer, asthma, heart disease, on World Health Day 2022, WHO will focus global attention on urgent actions needed to keep humans and the planet healthy and foster a movement to create societies focused on well-being.
WHO estimates that more than 13 million deaths around the world each year are due to avoidable environmental causes. This includes the climate crisis which is the single biggest health threat facing humanity. The climate crisis is also a health crisis.
Women in Recovery Specialty Online Training Series: Adapting and Addressing Tobacco Use with Telehealth for the Pregnant Population
Friday, April 8, 2022 @ 12:00-1:30pm ET (11CT/10MT/9PT)
This presentation will address components of tobacco use and treatment for the pregnant and postpartum population. The first segment will include an overview of the latest research on tobacco use within the pregnant population and the negative impact of tobacco use on specific social and racial groups.
The Clinician’s Guide to Addressing Medical Cannabis in Substance Use Treatment Settings
According to the National Survey on Drug Use and Health, cannabis use rates increased in 2020, with almost 50 million individuals 12 or older reporting use of cannabis in the past year. This increase is reflected in the state-specific data for HHS Region 8 in five of the six states (Colorado, Montana, North Dakota, South Dakota, and Utah).
Location: Washington, D.C., metropolitan area, United States
The National Council for Mental Wellbeing invites you to join thousands of professionals representing the very best of the field as they convene at NatCon22, the largest conference in mental health and substance use treatment, from April 11-13, 2022, to be held at the Gaylord National Resort & Convention Center in the Washington, D.C., metropolitan area.
NatCon22 registration allows you to:
Engage in unparalleled networking opportunities connecting with peers and luminaries, including Monday evening’s Opening Reception.
The UK-Ireland Alcohol Research Network (AcoRN) would like to invite you to its third webinar, which will be held via Zoom on Wednesday 13th April from 10-11:30am. The webinar will be focused on the availability of alcohol and feature the following inputs:
• An overview of recent and current policy developments across the island of Ireland, Dr Joanna Purdy (Public Health Ireland)
Join NAADAC for our 2022 Advocacy in Action Conference & Virtual Hill Day on April 19-21, 2022! Attend briefings on current legislation, learn about important advocacy issues, and earn up to 13 CEs! On Virtual Hill Day, attendees can speak directly with lawmakers on Capitol Hill about the issues that affect the addiction profession and those it serves.
Scottish Health Action on Alcohol Problems (SHAAP) and the Scottish Alcohol Research Network (SARN) invite you to join us online on Wednesday 20 April from 12.30-14.00 BST (UK time) for our second SHAAP/SARN Alcohol Occasionals event of 2022.
Dr Inge Kersbergen and Dr Laura Fenton will present "Youth drinking in decline: Implications for policy and practice".
Women in Recovery Specialty Online Training Series: Substance Use Disorders (SUD) and Mood Disorders in Postpartum Women
Friday, April 22, 2022 @ 12:00-1:30pm ET (11CT/10MT/9PT)
Substance use during and/or after pregnancy increased dramatically during the pandemic, putting women and their babies at risk. Substance use during or after pregnancy can lead to threats to the unborn or nursing infant, severe social stigma to the mother, and parental rights concerns. New mothers often feel compelled to keep their substance use hidden for fear of losing their child, thus making it difficult to properly diagnose and administer treatment.
Wednesday, April 27, 2022 @ 3:00-4:00pm ET (2CT/1MT/12PT)
As a result of the opioid crisis, more and more primary care providers are being asked to treat those suffering from opioid use disorder (OUD) through the use of medication assisted treatment (MAT). This course will cover the United States Drug Enforcement Administration's (DEA) authority and role relative to MAT along with SAMHSA requirements and resources, patient limits, and red flags.